HLA-G and cancer: Two clinical studies are currently underway in cancer patients: the first for the treatment of patients with different types of cancer using the human mAb TTX-080 directed against HLA -G, and the second using the bispecific antibody JNJ-78306358 directed against HLA-G and CD3 (64).